Public Notice: Affirmative Action Order of the Controlled Substances Board re. Eluxadoline

STATE OF WISCONSIN

Controlled Substances Board

IN THE MATTER OF RULE-MAKING PROCEEDINGS BEFORE THE

CONTROLLED SUBSTANCES BOARD

AFFIRMATIVE ACTION ORDER OF THE

CONTROLLED SUBSTANCES BOARD

FINDINGS

1. On November 12, 2015 , the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register placing eluxadoline into schedule I V of the federal Controlled Substances Act. The scheduling action is effective December 17, 2015 .

2. The Controlled Substances Board did not receive an objection to similarly treating eluxadoline as a schedule I V under ch. 961 , Stats. within 30 days of the date of publication in the federal register of the final order designating eluxadoline as a controlled substance.

3. The Controlled Substances Board will promulgate a final rule , without making the determinations or findings required by ss. 961.11(1) , (1m) , (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making , designating eluxadoline as a schedule I V controlled substance .

ORDER

Pursuant to s. 961.11(4) , Stats., t he Controlled Substances Board by affirmative action similarly treats eluxadoline under chapter 961, Stats. by creating the following :

CSB 2. 4 8 Addition of eluxadoline to schedule I V . Section 961. 20 ( 4 ) ( cm ) , Stats., is created to read:

961. 20 ( 4 ) ( cm ) Eluxadoline , including any of its isomers, and salts of isomers .

This order shall take effect on November 21 , 201 6 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.

Dated 11-15-16           /s/ Doug Englebert    

              Doug Englebert, Chair

              Controlled Substances Board